For instance miR-101, reported to act as inhibitor of autophagy in breast cancer by targeting STMN1, RAB5A, and ATG4D mRNAs [109], has been found downregulated also in ovarian cancer compared to normal tissue, and its reexpression exerted tumour-suppressive effects in ovarian carcinogenesis [110]. Here, STMN1 is linked to ovarian carcinoma.